<aside> 🧫 Reducing the time to market for new therapies by replacing animal trials with AI-assisted cultivation of disease models from human cells

</aside>

3D CELL CULTURE

Enabling a Paradigm Shift from disease-centred to patient-centred medicine

We develop the Micro-Lab, a compact and easy-to-use robotic & software platform that establishes a new standard for achieving during a research study. Automation & AI-assisted cultivation processes ensure cell survival and standardisation even during long-term studies, reaching unprecedented traceability and reproducibility for research publications and regulatory approval.

As opposed to conventional pre-clinical animal models, disease models are miniaturised replicates of organs or tissues, such as a tumour, derived from human cells on which therapies can be tested.

3D cell culture has the potential to revolutionise life science research by providing more conclusive disease models early on, bridging the gap between conventional in vitro cultures and complex in vivo environments.

[1] Begley, C., Ellis, L. Raise standards for preclinical cancer research. Nature 483, 531–533 (2012). https://doi.org/10.1038/483531a

[2] Prinz, F., Schlange, T. & Asadullah, K. Believe it or not: how much can we rely on published data on potential drug targets?. Nat Rev Drug Discov 10, 712 (2011). https://doi.org/10.1038/nrd3439-c1